UNSPSC 51283409: Procaine benzylpenicillin or procaine penicillin g

This classification denotes a penicillin antibiotic with the molecular formula C16H18N2O4S.C13H20N2O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17R794ESYN. European Medicines Agency schedules procaine benzylpenicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26570. The term penicillin g procaine is a U.S. FDA designation. SMILES: CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.O.

UNSPSC 51283409 Procaine benzylpenicillin or procaine penicillin g is a Commodity code, but the recent state and local opportunities posted under this code do not reflect procurement of procaine penicillin or related penicillin products. The two most recent opportunities on record involve entirely different pharmaceutical products: an Illinois Department of Public Health piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida bid for Naloxone and Safe Drug Deactivation Systems. Neither opportunity solicits procaine penicillin or related penicillin-class antibiotics. The code shows little relevant recent activity aligned with its nominal scope.

The Illinois opportunity (Solicitation 26482DPHPREPDB53392, posted August 28, 2026, due September 11, 2026) was an IFB through the MMCAP Infuse consortium that awarded $2,999,999.11 over three years to Chartwell Rx LLC for antibiotic tablets supplied via piggyback warehouse contract. The Seminole County opportunity (IFB60459723LAS, posted June 30, 2026) sought annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries; this procurement was potentially FEMA-funded and included federal compliance requirements. Activity under this Commodity code appears concentrated in state health departments and county health authorities, but the mismatch between the code's stated scope and the actual products being solicited suggests either tagging errors in the source data or a disconnect between the taxonomy classification and current procurement practice for this drug category.